Free tool
FAERS Monitor: Diflucan
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019949 or its brand name (Diflucan, Fluconazole). Reports on generic versions are filed under their own applications.
Reports
70,762
Serious
59,877
85% of reports
Hospitalization
31,022
Death reported
12,605
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective5,269
- off label use4,705
- pyrexia4,261
- nausea3,868
- diarrhoea3,655
- fatigue3,320
- pain3,210
- drug interaction3,089
- headache2,999
- pneumonia2,937
- febrile neutropenia2,741
- rash2,522
- dyspnoea2,504
- vomiting2,440
- acute kidney injury2,217
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,081 |
| 2005 | 1,191 |
| 2006 | 1,243 |
| 2007 | 1,184 |
| 2008 | 1,359 |
| 2009 | 1,567 |
| 2010 | 1,650 |
| 2011 | 2,504 |
| 2012 | 2,479 |
| 2013 | 2,100 |
| 2014 | 2,290 |
| 2015 | 3,173 |
| 2016 | 3,829 |
| 2017 | 3,887 |
| 2018 | 5,023 |
| 2019 | 5,586 |
| 2020 | 5,251 |
| 2021 | 4,995 |
| 2022 | 4,531 |
| 2023 | 4,172 |
| 2024 | 4,469 |
| 2025 | 4,315 |
| 2026 | 2,874 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,983,397 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| febrile neutropeniaSignal | 2,741 | 12.8 | 12.3 | 28,581 |
| drug interactionSignal | 3,089 | 5.9 | 5.7 | 12,363 |
| acute kidney injurySignal | 2,217 | 4.4 | 4.2 | 5,684 |
| pyrexiaSignal | 4,261 | 3.7 | 3.6 | 8,402 |
| pneumoniaSignal | 2,937 | 2.7 | 2.6 | 3,192 |
| rash | 2,522 | 1.7 | 1.7 | 778 |
| diarrhoea | 3,655 | 1.7 | 1.6 | 1,048 |
| off label use | 4,705 | 1.6 | 1.6 | 1,099 |
| pain | 3,210 | 1.6 | 1.5 | 653 |
| vomiting | 2,440 | 1.5 | 1.5 | 477 |
| nausea | 3,868 | 1.5 | 1.4 | 568 |
| headache | 2,999 | 1.4 | 1.4 | 388 |
| dyspnoea | 2,504 | 1.3 | 1.3 | 194 |
| fatigue | 3,320 | 1.3 | 1.2 | 195 |
| drug ineffective | 5,269 | 1.2 | 1.2 | 168 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.